pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    (pramipexol + ondansetron)
    (pramipexol + ondansetron [INN])
    Treatment Resistant Depression$ANRO Alto Neuroscience, Inc.
  • Marketed
    (prednisolone sodium phosphate + sulfacetamide sodium)
    Sulfacetamide Sodium + Prednisolone Sodium Phosphate ((prednisolone sodium phosphate + sulfacetamide sodium))
    Anterior Uveitis Bausch Health US LLC
  • Phase 2
    (prednisone + valproate sodium)
    (prednisone [INN] + valproate sodium)
    Diffuse Large B-Cell Lymphoma Respiratorius AB
← prev
page 45 of 231
next →
131
Pain89
Neurology1
  • Marketed
    (probenecid + sulopenem etzadroxil)
    Orlynvah ((probenecid [INN] + sulopenem etzadroxil))
    Urinary Tract Infections$ITRMF Iterum Therapeutics plc
  • Marketed
    (prothrombin + (coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C + protein S)
    Balfaxar ((prothrombin + (coagulation factor II (human) + coagulation factor VII (human) + coagulation factor IX (human) + coagulation factor X (human) + protein C + protein S))
    Bleeding And Clotting Disorders Octapharma USA Inc
  • Phase 3
    (riboflavin + sodium iodide)
    (riboflavin [INN] + sodium iodide [USP])
    Keratoconus Epion Therapeutics Inc
  • Preclinical
    (rifampin + polymyxin B + trimethoprim)
    (rifampin + polymyxin B [INN] + trimethoprim)
    Bacterial Keratitis University of Rochester
  • Marketed
    (sacubitril + valsartan)
    Sacubitril + Valsartan ((sacubitril + valsartan))
    Cardiovascular Risk Factors Novugen Pharma (Malaysia) Sdn Bhd
  • Phase 2
    (segesterone acetate + testosterone)
    (segesterone acetate + testosterone [INN])
    Male Contraception Contraline Inc
  • Phase 2
    (senaparib + temozolomide)
    (senaparib [INN] + temozolomide)
    Small-Cell Lung Cancer IMPACT Therapeutics Inc
  • Marketed
    (sodium benzoate + sodium phenylacetate)
    Sodium Benzoate + Sodium Phenylacetate Oceanside ((sodium benzoate + sodium phenylacetate))
    Encephalopathy Oceanside Pharmaceuticals Inc
  • Marketed
    (sodium nitrite + sodium thiosulfate)
    Nithiodote ((sodium nitrite + sodium thiosulfate))
    Poisoning Hope Biosciences LLC
  • Phase 2
    (sodium phenylbutyrate + taurursodiol)
    (sodium phenylbutyrate + taurursodiol)
    Unspecified Genetic Disorders$AMLX Amylyx Pharmaceuticals, Inc.
  • Marketed
    (sofosbuvir + velpatasvir + voxilaprevir)
    Vosevi ((sofosbuvir + velpatasvir + voxilaprevir))
    Hepatitis C$GILD GILEAD SCIENCES, INC.
  • Marketed
    (sofosbuvir + velpatasvir)
    Sofosbuvir + Velpatasvir Asegua ((sofosbuvir + velpatasvir))
    Hepatitis C Asegua Therapeutics LLC
  • Marketed
    (sulfamethoxazole + trimethoprim)
    Sulfamethoxazole + Trimethoprim ((sulfamethoxazole + trimethoprim))
    Enteritis Vista Pharmaceuticals Inc
  • Marketed
    (tipiracil hydrochloride + trifluridine)
    Lonsurf ((tipiracil hydrochloride + trifluridine))
    Adenocarcinoma Of The Gastroesophageal Junction Taiho Oncology Inc
  • Preclinical
    (tobramycin + vancomycin)
    Surgical Wound Infections Sonoran Biosciences Inc
  • Marketed
    (trandolapril + verapamil hydrochloride) ER
    Trandolapril + Verapamil Hydrochloride ((trandolapril [INN] + verapamil hydrochloride))
    Hypertension Glenmark Pharmaceuticals Ltd
  • Marketed
    (trospium chloride + xanomeline tartrate)
    Cobenfy ((trospium chloride + xanomeline tartrate))
    Psychosis Bristol-Myers Squibb Co
  • Marketed
    (umeclidinium bromide + vilanterol trifenatate)
    Anoro Ellipta ((umeclidinium bromide + vilanterol trifenatate))
    Chronic Bronchitis GlaxoSmithKline LLC
  • Preclinical
    15d-PMJ2
    Colon Cancer Claradele Pharmaceuticals Inc
  • Phase 2
    177Lu-LNC-1011
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Yantai Lannacheng Biotechnology Co Ltd
  • Preclinical
    188-RNLBAM
    Hepatocellular Carcinoma$PSTV PLUS THERAPEUTICS, INC.
  • Phase 2
    2-DG
    Epilepsy Hexokine Therapeutics Inc
  • Phase 1
    212Pb-GRPR
    Cervical Cancer Orano Med LLC
  • Preclinical
    212Pb-LNC-1011
    Prostate Cancer Yantai Lannacheng Biotechnology Co Ltd
  • 3% SODIUM CHLORIDE
    3% SODIUM CHLORIDE
    no indication FRESENIUS KABI USA
  • Preclinical
    3-HOTP
    Obesity 3H Bio Co Ltd
  • Preclinical
    3D-059
    Unspecified Cancer$SLS SELLAS Life Sciences Group, Inc.